FDA approves Roche ’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer
Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung cancer (NSCLC)1This approval helps address an urgent unmet need, with abouthalf of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy2TheNational Comprehensive Cancer Network ® (NCCN®)Guidelines recommend routine testing for ALK, EGFR and PD-L1 biomarkers in people with early-stage NSCLC to inform adjuvant therapy selectionBasel, 19 April 2024 - Roche (SIX: RO,...
Source: Roche Investor Update - April 19, 2024 Category: Pharmaceuticals Source Type: news
FDA approves Roche ’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer
Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung cancer (NSCLC)1This approval helps address an urgent unmet need, with abouthalf of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy2TheNational Comprehensive Cancer Network ® (NCCN®)Guidelines recommend routine testing for ALK, EGFR and PD-L1 biomarkers in people with early-stage NSCLC to inform adjuvant therapy selectionBasel, 19 April 2024 - Roche (SIX: RO,...
Source: Roche Media News - April 19, 2024 Category: Pharmaceuticals Source Type: news
Urine Test for Detecting Head and Neck Cancer
At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests (Source: Disabled World)
Source: Disabled World - April 16, 2024 Category: Disability Tags: Head, Neck, and Oral Cancer Source Type: news
How a lollipop can help to spot the early signs of mouth cancer
When the fruit-flavoured sweet, which is being developed by scientists at Birmingham University, is sucked for just a few minutes, the proteins - released by mouth cancer cells - become 'stuck' (Source: the Mail online | Health)
Source: the Mail online | Health - April 15, 2024 Category: Consumer Health News Source Type: news
April is Oral Cancer Awareness Month: Self-exams, early detection can save lives
The American Association of Oral and Maxillofacial Surgeons (AAOMS) is reminding the public during Oral Cancer Awareness Month of the importance of performing monthly self-exams. ROSEMONT, Ill., April 11, 2024 /PRNewswire-PRWeb/ -- Early detection of oral cancer offers a greater chance of... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 11, 2024 Category: Pharmaceuticals Source Type: news
Why a New Study Dubbed India the ‘Cancer Capital of the World’
A new study has unveiled an alarming picture of declining overall health in India. The report, released by the Indian multinational healthcare group, Apollo Hospitals, found that skyrocketing cases of cancer and other non-communicable diseases across the country have now made it “the cancer capital of the world.”
[time-brightcove not-tgx=”true”]
Despite reporting more than a million new cases every year, India’s cancer rate has not yet surpassed countries like Denmark, Ireland, and Belgium, which record some of the highest cancer rates in the world. It is also currently lower than the U.S....
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Astha Rajvanshi Tags: Uncategorized India Source Type: news
Experts warn morning breath could be a red flag sign of killer cancer
If improving your oral hygiene doesn't get rid of bad breath it is time to see a health professional, an expert has warned. (Source: Daily Express - Health)
Source: Daily Express - Health - March 25, 2024 Category: Consumer Health News Source Type: news
How to Manage Anxiety and Depression When You Have Kidney Cancer
When Katie Coleman was diagnosed at age 29 with a softball-sized tumor on her right kidney and a host of smaller growths in her liver, she was stunned. That astonishment quickly gave way to feelings of hopelessness. “I felt like my entire world was being pulled out from under me,” Coleman, now 32, says. “I went into a very dark spiral.”
Though her surgeon removed all the tumors, it wasn’t clear what her long- or even short- term prognosis was. What she found on the internet just freaked her out more. “One night I spiraled so deep I didn’t know whether life was worth living anymo...
Source: TIME: Health - March 22, 2024 Category: Consumer Health News Authors: Linda Carroll Tags: Uncategorized freelance healthscienceclimate Source Type: news
Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer
(MedPage Today) -- T-cell malignancies represent a small fraction of secondary cancers in patients treated with CAR T-cell therapy. (American Society of Hematology)
In an update to a clinical guideline, the American Society of Clinical Oncology... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 22, 2024 Category: Hematology Source Type: news
A Bacteria in the Mouth Might Speed Colon Cancers
THURSDAY, March 21, 2024 -- A germ commonly found in the human mouth can travel to colon tumors and appears to speed their growth, new research shows.
The finding might lead to new insights into fighting colon cancer, which kills more than 52,000... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 21, 2024 Category: General Medicine Source Type: news
Bacteria commonly found in the body contribute to stomach cancer
A new study has discovered that a type of bacteria commonly found in the body, which usually does not pose problems for healthy people, plays a significant role in causing stomach cancer, the fifth most common cancer in the world.
Streptococcus anginosus bacteria exist alongside other germs in the mouth, throat, intestines and vagina. Occasionally, they may cause mild infections like sore throats and skin infections. (Source: World Pharma News)
Source: World Pharma News - March 18, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Calcifications on mammo could identify women at risk of CVD
Detecting breast arterial calcifications on routine mammograms could identify women at a higher risk of future cardiovascular disease (CVD), a study published March 13 in Clinical Imaging found.
Researchers led by Shadi Azam, PhD, from Weill Cornell Medicine in New York found links between such calcifications and older age, diabetes, parity, younger age at first birth, and hypertension in women who underwent both screening mammography and cardiac CT angiography (CCTA).
“Additionally, we found that when neither breast arterial calcifications nor coronary arterial calcifications were present, the estimated 10-year risk o...
Source: AuntMinnie.com Headlines - March 15, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news
Eliminating Medicaid dental benefits and early-stage oral cancer diagnoses
ConclusionsEliminating Medicaid dental benefits negatively impacted early detection of cancers of the oral cavity. Continued volatility of Medicaid dental coverage and provider shortages may be further delaying oral cancer diagnoses. Alternative approaches are needed to prevent advanced stage OPC. (Source: Dental Technology Blog)
Source: Dental Technology Blog - March 13, 2024 Category: Dentistry Source Type: news
Beta-defensin index: A functional biomarker for oral cancer detection
Cell Reports Mediine AccessPublished:March 04, 2024DOI:https://doi.org/10.1016/j.xcrm.2024.101447SummaryThere is an unmet clinical need for a non-invasive and cost-effective test for oral squamous cell carcinoma (OSCC) that informs clinicians when a biopsy is warranted. Human beta-defensin 3 (hBD-3), an epithelial cell-derived anti-microbial peptide, is pro-tumorigenic and overexpressed in early-stage OSCC compared to hBD-2. We validate this expression dichotomy in carcinoma in situ and OSCC lesions using immunofluorescence microscopy and flow cytometry. The proportion of hBD-3/hBD-2 levels in non-invasivel...
Source: Dental Technology Blog - March 12, 2024 Category: Dentistry Source Type: news
Drug Discount May Boost Adherence to Prostate Cancer Therapy Drug Discount May Boost Adherence to Prostate Cancer Therapy
The 340B drug discount program was not associated with oral specialty drug use in advanced prostate cancer but was linked to better adherence to medication in more vulnerable patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 11, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
